Rockwell Medical (RMTI) Amortizatization of Intangibles (2022 - 2026)
Rockwell Medical's (RMTI) quarterly Amortizatization of Intangibles came in at $102000.0 in Q1 2026, down 26.62% YoY from $139000.0 in Q1 2025, and up 0.99% on a QoQ basis from $101000.0 in Q4 2025.
Rockwell Medical (RMTI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 5 years of Amortizatization of Intangibles data on file, last reported at $102000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 26.62% year-over-year to $102000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $451000.0 (down 19.03% YoY) and the FY2025 annual result came in at $488000.0, down 12.7% from the prior year.
- Amortizatization of Intangibles advanced to $102000.0 in Q1 2026, from $101000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $142000.0 in Q3 2023 to a low of $101000.0 in Q4 2025.
- A 5-year average of $133562.5 and a median of $141000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles rose 0.71% — and 2025, when it dropped 26.81%.
- Tracing RMTI's Amortizatization of Intangibles over 5 years: stood at $141000.0 in 2022, then changed by 0.0% to $141000.0 in 2023, then fell by 2.13% to $138000.0 in 2024, then dropped by 26.81% to $101000.0 in 2025, then advanced by 0.99% to $102000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $102000.0 (Q1 2026), $101000.0 (Q4 2025), and $109000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 101,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101,000.00 |
| Jun 30, 2026 | 101,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |